This year s distinguished faculty of legal and industry experts from Canada and the U.S. will provide you with current, in-depth information on the latest legal developments and regulatory changes in pharmaceutical and biotechnology patents.
Session highlights include:
- Case law on selection patents sound prediction: what is required?
- File histories: alive and well in PM(NOC) litigation?
- Canada s pharmaceutical price review regime and trends
- Settling pharma patent cases: when to, how to and obstacles to
- Improving access to medicines with a pharmaceutical patent pool: legal/business and antitrust considerations
- South of the border: the year in review
- Strategies in pharma patent litigation
- Ground breaking decisions: how the landscape has changed for 2010
- Canadian duty of good faith vs. the U.S.: where the law is headed
